Cours Audentes Therapeutics, Inc.
Actions
US05070R1041
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Andrew Krivoshik
PSD | President | - | - |
Morten Sogaard
COO | Chief Operating Officer | - | 01/05/22 |
Jason Schwartz
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Kush Parmar
BRD | Director/Board Member | 42 | 01/07/13 |
Alan Beggs
BRD | Director/Board Member | - | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+8,96% | 105 Md | |
-1,43% | 104 Md | |
+4,40% | 22,94 Md | |
-12,15% | 22,34 Md | |
-4,36% | 19,25 Md | |
-39,98% | 17,08 Md | |
-10,04% | 16,96 Md | |
+6,79% | 14,16 Md | |
+38,61% | 12,63 Md |